Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Journal of the American Heart Association|March 29, 2021
Adipokines and Subclinical Cardiovascular Disease in Post-Menopausal Women: Study of Women's Health Across the NationSusan A Everson-Rose, Emma J M Barinas-Mitchell, Samar R El Khoudary, et al.
Epidemiology (Cambridge, Mass.)|November 25, 2015
Long- and Short-term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife WomenRochelle Green, Rachel Broadwin, Brian Malig, et al.
European Journal of Preventive Cardiology|September 20, 2015
Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopauseSamar R El Khoudary, Nanette Santoro, Hsiang-Yu Chen, et al.
Msystems|June 8, 2022
Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of LatinosBrandilyn A Peters, Juan Lin, Qibin Qi, et al.
Journal of the American Heart Association|November 29, 2018
Healthy Lifestyle During the Midlife Is Prospectively Associated With Less Subclinical Carotid Atherosclerosis: The Study of Women's Health Across the NationDongqing Wang, Elizabeth A Jackson, Carrie A Karvonen-Gutierrez, et al.
Maturitas|April 9, 2021
Lowered progesterone metabolite excretion and a variable LH excretion pattern are associated with vasomotor symptoms but not negative mood in the early perimenopausal transition: Study of Women's Health Across the NationDaniel S McConnell, Sybil L Crawford, Nancy A Gee, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 25, 2020
The Importance of Engaging in Physical Activity in Older Adulthood for Transitions Between Cognitive Status Categories and Death: A Coordinated Analysis of 14 Longitudinal StudiesTomiko Yoneda, Nathan A Lewis, Jamie E Knight, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant RecipientsJulie H Ishida, Anita Patel, Aneesh K Mehta, et al.
Plos One|August 21, 2019
Promoting cardiovascular health and wellness among African-Americans: Community participatory approach to design an innovative mobile-health interventionLaPrincess C Brewer, Sharonne N Hayes, Amber R Caron, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge ModelJacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.
Pageof 22